1. Market Research
  2. > Pharmaceutical Market Trends
Europe Small Molecule Drug Delivery Market Forecast to 2027 – COVID-19 Impact and Country Analysis – by Therapeutic Area ; Process/Phase, and Country

Europe Small Molecule Drug Delivery Market Forecast to 2027 – COVID-19 Impact and Country Analysis – by Therapeutic Area ; Process/Phase, and Country

  • August 2020
  • 101 pages
  • ID: 5953784
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Dec 10th 2020


Table of Contents

Search Inside

Europe small molecule drug delivery market is expected to reach US$ 13,381.71 million by 2027 from US$ 6,835.97 million in 2019. The market is anticipated to grow with a CAGR of 9.0% from 2020 to 2027.
The growth of the Europe small molecule drug delivery market is estimated to grow owing to the key factors such as growing demand for R&D from contract organizations along with the growing developments and start-ups in small molecules. However, high cost associated with drug development is the major factor hindering the market growth.
There are a growing number of drug delivery companies (DDC) actively seeking for appropriate drug candidates for unique delivery systems.These DDCs, sometimes do serve as the contract manufacturer.

Many larger and traditional CROs are focused on small molecule NCEs and generics.These contract providers are therefore working to build specialty groups to deal with the frequently diverse and specialized needs such as gene therapy, cytotoxic drugs, and biotechnology product Hence, large pharmaceutical companies are outsourcing R&D activities to increase the speed of the drug development process, along with reducing their development and manufacturing costs.

In the last few years, the pharmaceuticals industry has witnessed rapid growth in outsourcing services, driven by many factors such as the growth of small molecules, increase in API complexities, and growing need to reduce development costs.
To minimize the high fixed costs of in-house development, manufacturing capabilities, and expertise, pharmaceutical firms rely on CROs.In the past two decades, the pharmaceutical research and development (R&D) ecosystem has been growing exponentially.

Drug Development & Delivery has stated that between 2001 and 2018, the number of therapeutic molecules under development and the number of companies engaged in research has more than doubled and tripled.However, according to most industry estimates, R&D failures remain high due to complexity in the development of new molecular entities (NMEs), and approximately 90% to 95% of drugs fail before reaching the marketplace.

With new drug approvals on the rise (the FDA approved 48 NMEs in 2019) robust clinical development pipeline and the demand for outsourcing have increased. Many biotechnology companies are taking advantage of CROs to expand their small molecule pipeline.
Based on the therapeutic area, the Europe small molecule drug delivery market was segmented into oncology, central nervous system, cardiovascular, respiratory, orthopedics, immunology, rare diseases, and other therapeutic areas.The oncology segment held the larger share of the market in 2019.

However, rare diseases is anticipated to register the higher CAGR in the market during the forecast period.
Based on process/phase, the Europe small molecule drug delivery market is segmented into target discovery, target validation, lead generation and refinement, and preclinical development. In 2019, the lead generation and refinement segment held the larger share of the market, however, target discovery segment is anticipated to register the higher CAGR in the market during the forecast period.
Some of the major primary and secondary sources for Europe small molecule drug delivery market included in the report are European Investment Bank (EIB), World Health Organization (WHO), National Center for Biotechnology Information (NCBI), and National Heart, Lung, and Blood Institute (NHLBI).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Mycoplasma Testing Market by Product & Service, Technique, Application, End User, Region - Global Forecast to 2025

  • $ 4950
  • November 2020
  • 150 pages

The global mycoplasma testing market size is valued at an estimated USD 689 million in 2020 and is projected to reach USD 1,095 million by 2025, at a CAGR of 9.7% during the forecast period. The global ...

  • United States
  • World
  • Life Sciences
  • Pharmaceutical
  • Industry analysis
  • Biologics Production
  • Health Expenditure


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on